CRIS Current Research Information System

DE LORENZO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.565
NA - Nord America 3.450
EU - Europa 2.199
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 231
SA - Sud America 134
OC - Oceania 5
Totale 9.829
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.377
VN - Vietnam 1.022
SG - Singapore 927
CN - Cina 905
IT - Italia 603
GB - Regno Unito 303
SE - Svezia 298
DE - Germania 231
HK - Hong Kong 172
KR - Corea 140
IN - India 130
NL - Olanda 121
FR - Francia 105
IE - Irlanda 102
CI - Costa d'Avorio 94
CH - Svizzera 91
RU - Federazione Russa 88
BR - Brasile 85
BD - Bangladesh 76
FI - Finlandia 68
SC - Seychelles 47
CA - Canada 42
TG - Togo 39
JP - Giappone 31
ZA - Sudafrica 30
AT - Austria 29
JO - Giordania 28
UA - Ucraina 27
BG - Bulgaria 22
NG - Nigeria 21
ID - Indonesia 20
TR - Turchia 20
BE - Belgio 19
AR - Argentina 18
EE - Estonia 18
PH - Filippine 18
GR - Grecia 16
PL - Polonia 16
TW - Taiwan 12
IQ - Iraq 11
PK - Pakistan 11
PS - Palestinian Territory 10
MX - Messico 9
ES - Italia 8
LT - Lituania 8
RO - Romania 8
EC - Ecuador 7
SA - Arabia Saudita 7
CL - Cile 6
NI - Nicaragua 6
TH - Thailandia 6
VE - Venezuela 6
EG - Egitto 5
JM - Giamaica 5
UZ - Uzbekistan 5
PE - Perù 4
CO - Colombia 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
BO - Bolivia 2
CR - Costa Rica 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DK - Danimarca 1
FJ - Figi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 9.599
Salva come PNG Salva come JPEG
Città #
Singapore 667
Ashburn 339
Hefei 318
Dallas 300
Southend 255
Chandler 238
Hanoi 228
Fairfield 225
Ho Chi Minh City 219
San Jose 205
Dong Ket 162
Hong Kong 157
Woodbridge 128
Houston 126
Seoul 121
Beijing 102
Dublin 102
Wilmington 101
Santa Clara 100
Boardman 99
Bologna 98
Abidjan 94
Seattle 93
Bern 82
Princeton 82
Council Bluffs 80
Cambridge 77
Ann Arbor 75
New York 75
Helsinki 62
Rome 50
Los Angeles 46
Da Nang 44
Frankfurt am Main 42
Lauterbourg 42
Turin 42
Lomé 39
Milan 39
Nanjing 35
Amman 28
Berlin 28
Haiphong 28
Bengaluru 27
Tokyo 25
Buffalo 24
Redondo Beach 23
Westminster 23
Sofia 22
San Diego 21
Redmond 18
Abeokuta 17
Chicago 17
London 17
Shanghai 17
São Paulo 17
Toronto 17
Guangzhou 16
Vienna 16
Brussels 15
Padova 15
Tongling 15
Phoenix 13
Ravenna 13
Florence 12
Jakarta 12
Munich 12
Warsaw 12
Des Moines 11
Düsseldorf 11
Jinan 11
Orem 11
Redwood City 11
Shenyang 11
Bến Tre 10
Can Tho 10
Changsha 10
Montreal 10
Ninh Bình 10
Amsterdam 9
Biên Hòa 9
Groningen 9
Olalla 9
The Dalles 9
Ankara 8
Bremen 8
Halhul 8
Hải Dương 8
Istanbul 8
Jacksonville 8
Long Xuyen 8
Norwalk 8
Nuremberg 8
Saint Petersburg 8
San Francisco 8
Vũng Tàu 8
Wuhan 8
Bari 7
Falkenstein 7
Forlì 7
Medford 7
Totale 6.202
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 470
Adjuvant treatment in biliary tract cancer 347
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 306
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 305
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 286
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 284
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 262
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 253
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 248
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 236
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 229
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 229
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 217
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 216
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 211
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 210
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 210
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 204
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 200
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 200
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 199
In Reply 196
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 195
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 190
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma 188
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 188
Should patients on levothyroxine therapy be screened for pancreatic cancer? 186
Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now? 185
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 180
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 176
Cholangiocarcinoma: From risk to prevention? 174
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 164
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 159
Treatment of combined hepatocellular and cholangiocarcinoma 156
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 155
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 155
Adjuvant Treatment and Follow-up Strategies 150
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 147
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 146
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 129
Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016 129
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 127
Regorafenib for the treatment of hepatocellular carcinoma 125
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 122
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 118
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 108
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 104
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? 102
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 90
null 75
Microbiota, NASH, HCC and the potential role of probiotics 73
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 59
null 56
Totale 9.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022849 0 46 46 64 74 29 30 67 84 61 219 129
2022/20231.180 114 169 56 115 84 77 46 68 207 58 60 126
2023/2024327 34 51 16 28 16 69 13 19 17 26 21 17
2024/20251.496 68 161 145 89 144 53 122 110 49 150 121 284
2025/20264.020 374 432 539 282 319 172 604 102 644 272 125 155
2026/2027185 102 83 0 0 0 0 0 0 0 0 0 0
Totale 9.829